肿瘤细胞治疗研究
ALL SOURCES
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic s
这些结果支持将 lisocabtagene maraleucel 作为未计划接受 HSCT 的大 B 细胞淋巴瘤患者的潜在二线治疗。
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE i
第七届多利益相关方儿科战略论坛聚焦于针对儿童和青少年癌症的嵌合抗原受体（CAR）T细胞。
Optimization of upfront therapy for adult acute lymphoblastic leukemia: a paradigm shift toward immunotherapy.
成人急性淋巴细胞白血病（ALL）的治疗方案正在演变，一线治疗现已纳入靶向免疫治疗药物。
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech
在该队列的 606 例患者中，96 例（16%）感染了 COVID-19，中位时间为 Evusheld 给药后 98.5 天。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
